Fact-checked by Grok 2 weeks ago

Cronobacter

Cronobacter is a of Gram-negative, facultatively , rod-shaped bacteria belonging to the family . These motile, non-spore-forming microbes are typically yellow-pigmented and exhibit resistance to and moderate temperatures, allowing survival in dry environments. The , reclassified in 2007 from the former species Enterobacter sakazakii, currently comprises seven recognized species: C. sakazakii, C. malonaticus, C. turicensis, C. dublinensis, C. muytjensii, C. condimenti, and C. universalis. Among these, C. sakazakii and C. malonaticus are the most frequently implicated in human infections. Cronobacter species are opportunistic pathogens that pose a significant threat, particularly to vulnerable populations such as neonates, premature infants, low-birth-weight babies, and immunocompromised individuals. They can cause severe, life-threatening illnesses including , , , and bacteremia, with mortality rates of approximately 40% worldwide for and cases (as of 2025), though over 20% in the . In infants, symptoms often include poor feeding, , fever or , , grunting respirations, and seizures, potentially leading to long-term neurological damage such as developmental delays or motor impairments if untreated. While rare in healthy adults, infections in the elderly or immunocompromised may manifest as urinary tract infections or wound infections. These are ubiquitous in the , found in , , , and animal products, and can contaminate food environments, leading to persistence in low-moisture foods like powdered (PIF), herbal teas, and starches. In , invasive Cronobacter infections among infants were added to the list of nationally notifiable diseases to improve tracking. often occurs during manufacturing or through improper handling, with outbreaks historically linked to PIF in neonatal intensive care units. factors such as the outer membrane protein OmpA contribute to their ability to invade intestinal cells and cross the blood-brain barrier. Prevention focuses on strict , using ready-to-feed formulas for at-risk infants, preparing PIF with heated to at least 70°C (158°F), and sanitizing feeding equipment to minimize exposure.

Biology and Characteristics

Morphology and Physiology

Cronobacter species are , rod-shaped , typically measuring 1–3 μm in length and 0.5–1 μm in width, with peritrichous flagella conferring to most species. These bacteria are facultatively , oxidase-negative, and catalase-positive, enabling them to thrive in diverse oxygen conditions while utilizing aerobic when possible. They exhibit positive reactions in the Voges-Proskauer test, indicating production, but are negative for and production, which aids in their differentiation from related . Biochemically, Cronobacter species ferment , dulcitol, and other carbohydrates such as glucose and , supporting their classification and detection in microbiological assays. Optimal growth occurs at temperatures between 37°C and 44°C, with a broader range of 6–45°C, allowing adaptation to and mild environmental stresses. They demonstrate notable tolerance to osmotic stress, growing in media with up to 6% NaCl, and exceptional resistance, which permits long-term survival in low-moisture environments such as powdered . On solid media like tryptic soy , Cronobacter colonies often appear yellow-pigmented due to the production of carotenoid-like compounds, a that facilitates preliminary visual and distinguishes them from non-pigmented relatives. This pigmentation, combined with their and biochemical profile, underscores their physiological versatility as opportunistic pathogens in food and clinical settings.

Habitat and Ecology

_Cronobacter species are ubiquitous environmental found in a variety of natural settings, including , , , and plant materials such as herbs and spices. These bacteria demonstrate remarkable adaptability to diverse ecological niches, persisting in both arid and moist conditions across agricultural and urban landscapes. In human-associated environments, Cronobacter is commonly detected in facilities, particularly those involved in production and powdered manufacturing, where it can colonize equipment and surfaces. The bacterium's persistence in these settings is facilitated by its ability to form biofilms on materials like and plastics, which protect it from cleaning agents and , thereby enhancing long-term survival in manufacturing pipelines. Cronobacter exhibits exceptional tolerance to low-moisture environments, surviving in desiccated states such as for over two years at , owing to physiological adaptations that mimic resistance without forming true endospores. This desiccation tolerance underscores its in dry food matrices and environmental . Ecologically, Cronobacter functions as an opportunistic environmental bacterium rather than a primary in natural ecosystems, where it likely plays roles in without causing widespread harm to non-host organisms. In agricultural contexts, transmission occurs primarily through contaminated sources, dust, and such as flies, which vector the from or plant residues to crops and processing areas. This environmental dissemination contributes to incidental food contamination, particularly in dry products like .

Taxonomy and Classification

Historical Classification

The genus Cronobacter was initially established through the description of Enterobacter sakazakii in 1980 by et al., who identified it as a novel species within the family based on biochemical and phenotypic analyses of 57 strains isolated from clinical specimens and food sources. These strains exhibited yellow-pigmented colonies and unique metabolic profiles, distinguishing them from other species, though initial placement in the genus reflected the limited phylogenetic tools available at the time. A significant taxonomic shift occurred in 2007 when Iversen et al. proposed reclassifying E. sakazakii into a new genus, Cronobacter, based on multilocus molecular analyses including full-length 16S rRNA gene sequencing, which revealed phylogenetic distances from Enterobacter exceeding generic thresholds. This proposal was formally validated in 2008, elevating Cronobacter to genus status and initially delineating five species: C. sakazakii, C. malonaticus, C. turicensis, C. muytjensii, and C. dublinensis, along with a genomospecies. Subsequent refinements in 2012 utilized multilocus sequence typing (MLST) to assess genetic diversity across global isolates, supporting the existing species boundaries and identifying clonal complexes associated with pathogenicity. By 2014, whole-genome sequencing further consolidated the genus into seven recognized species, incorporating C. universalis and C. condimenti, and confirming the polyphyletic nature of prior Enterobacter groupings through comparative genomics. The reclassification gained international regulatory acknowledgment in 2008, when the (FAO) and (WHO) issued a microbiological report on sakazakii (noting the emerging Cronobacter nomenclature), which highlighted its role as a distinct opportunistic in neonatal infections and prompted updated guidelines for powdered safety. Similarly, the U.S. (FDA) incorporated Cronobacter into its Bacteriological Analytical Manual that year, establishing it as a reportable foodborne hazard and leading to enhanced detection protocols and industry regulations. The genus name Cronobacter derives from the Greek "Cronos", the who devoured his newborn children (alluding to the organism's threat to neonates), combined with the "bakterion" (small rod).

Species Diversity

The genus Cronobacter comprises seven validly published species as of 2025: C. sakazakii (the type species and source of most clinical isolates), C. malonaticus, C. turicensis, C. muytjensii, C. dublinensis, C. universalis, and C. condimenti. These species were delineated through polyphasic taxonomic approaches, including 16S rRNA gene sequencing, multilocus sequence analysis, and phenotypic profiling, following the reclassification of the former Enterobacter sakazakii into the genus in 2007. Genomes of Cronobacter species typically range from 4.3 to 5.4 in , with an average G+C content of approximately 57%. Plasmids in these species often harbor genes associated with adaptive functions, such as those involved in iron acquisition systems. Full genome assemblies reveal core genomic features conserved across the , including housekeeping genes for and response, while accessory elements contribute to species-specific traits. Phenotypic distinctions among Cronobacter species are primarily based on biochemical profiles, enabling identification via standard tests. For instance, C. malonaticus uniquely utilizes malonate as a carbon source, whereas C. sakazakii does not; other show variable reactions. Biogroups within species, such as those in C. sakazakii, are further differentiated by reactions to substrates like dulcitol, production, and , with traditional schemes dividing C. sakazakii into biogroups 1–15 based on these profiles. These traits, combined with growth on selective media like violet red glucose , support species-level differentiation without relying on genetic methods alone. Multilocus sequence typing (MLST) has revealed clonal complexes that reflect evolutionary relationships and population structure within Cronobacter. Clonal Complex 1, predominantly comprising C. sakazakii sequence types like ST1 and ST4, is the most prevalent in clinical and isolates, indicating its epidemiological significance. CRISPR-Cas arrays serve as additional markers for strain tracking, with spacer profiles varying by and enabling high-resolution subtyping for outbreak investigations. Recent studies from 2024–2025 have highlighted increasing genomic diversity across Cronobacter species, including analyses that uncover novel accessory genes and potential drivers of adaptation in food and environmental niches. These investigations suggest the possibility of new subspecies or genomovars, particularly within C. dublinensis and C. condimenti, based on whole-genome sequencing of diverse isolates, though formal taxonomic proposals await further validation.

Pathogenicity and Virulence

Virulence Mechanisms

Cronobacter species employ several molecular mechanisms to adhere to and invade host tissues, primarily through outer membrane proteins such as OmpA and OmpX. OmpA facilitates binding to intestinal epithelial cells and endothelial cells, enabling the bacterium to traverse the gastrointestinal barrier and cross the blood-brain barrier in severe infections. Similarly, OmpX contributes to adhesion and basolateral invasion, promoting translocation to deeper tissues. Invasion and intracellular survival are supported by the type VI secretion system (T6SS), which delivers effectors that induce in host cells, such as HEp-2 cells, leading to elevated release and cell damage. Cronobacter also exhibits robust tolerance to environmental stressors in the gut, including salts up to 5% concentration and low around 4.5, allowing survival during gastric transit and duodenal exposure. These adaptations, combined with T6SS-mediated effects, enhance the bacterium's ability to persist intracellularly in macrophages and epithelial cells. Toxin production in Cronobacter is limited, with few strains producing enterotoxins that cause fluid accumulation in ligated ileal loops; however, the primary is the Cronobacter (), encoded on pESA3, which activates host plasminogen to promote and tissue invasion. OmpA further augments this by binding plasminogen on the bacterial surface, facilitating degradation and dissemination. also confers resistance to bactericidal activity, aiding survival in . Immune evasion strategies include the production of capsule-like structures and formation, which shield the bacterium from by immune cells and . Additionally, iron acquisition systems, such as the cronobactin (aerobactin-like ) encoded on plasmids and the Eit receptor system, enable growth in iron-limited environments, supporting during systemic spread. In neonates, Cronobacter exploits the immature gut mucosa, characterized by underdeveloped microflora and epithelial barriers, to achieve efficient translocation from the intestine to the bloodstream and beyond. This vulnerability facilitates rapid dissemination, often leading to severe infections like .

Associated Diseases

Cronobacter infections predominantly affect neonates and infants, causing life-threatening conditions such as , (), and bacteremia or septicemia. , the most severe manifestation, is characterized by a mortality rate of 40-80%, with survivors often facing significant neurological sequelae including , developmental delays, and in 25-50% of cases. , an inflammatory intestinal disease, leads to tissue death in the bowel and is particularly devastating in preterm infants, contributing to high morbidity and prolonged hospitalization. Bacteremia and septicemia involve systemic spread of the , resulting in overwhelming that can progress rapidly to multi-organ failure. Overall case fatality rates for invasive Cronobacter infections in infants reach up to 40%. The 2024 CDC surveillance criteria define invasive infections as those with positive cultures from sterile sites such as blood or . Clinical symptoms in affected infants typically begin with nonspecific signs like fever, , and poor feeding, reflecting the organism's entry via the . In severe cases, particularly with , symptoms escalate to apnea, seizures, bulging , and lethargy, necessitating immediate intensive care intervention. These presentations are most common in neonates under 3 months of age, especially preterm or low-birth-weight infants, who lack mature immune defenses. While infants bear the brunt of severe , immunocompromised adults and the elderly are also vulnerable to Cronobacter , though cases are rarer and less . In these populations, may present as bacteremia, with higher risks among those over 65 years or with weakened immunity. Documented adult cases include wound and urinary tract , often linked to contaminated medical devices or indwelling catheters, leading to localized or systemic complications.

Epidemiology and Transmission

Global Prevalence

Cronobacter species are ubiquitous in the , with detection rates in and samples ranging from 3% to 23% across efforts, and higher prevalence observed in arid and dust-prone regions due to their desiccation tolerance. For instance, a multinational study reported 5% positivity in 835 environmental samples including and sources. These findings underscore the bacterium's persistence in natural reservoirs, contributing to potential contamination pathways for food production. In food products, contamination rates vary significantly by type and region, with powdered (PIF) showing 1% to 12.8% positivity globally; U.S. FDA surveys indicate less than 1% in domestic PIF, while rates reach up to 11.5% in samples from developing countries like . exhibit higher contamination, up to 34%, serving as potential reservoirs. Follow-up formulae similarly show 12.8% rates in some assessments. Cronobacter infections are rare, with an estimated incidence of 1–10 per 100,000 live births in neonates, though underreporting may occur in low-resource settings. Asymptomatic human carriage of Cronobacter is low, occurring in 0.5% to 2% of healthy adults' fecal samples and up to 1% in neonatal intestinal tracts, with higher rates in environments. Geographic trends reveal elevated incidence in and , linked to sanitation challenges, where prevalence in PIF and flours exceeds 10% in multiple provinces; in contrast, reports sporadic positives through monitoring programs initiated in 2008. Recent 2024-2025 studies highlight increased detection of Cronobacter in plant-based foods, such as dried functional products, with metagenomic approaches revealing up to 25% contamination in U.S. household settings and broader across food systems. These updates emphasize emerging risks in non-dairy alternatives.

Documented Outbreaks

Early outbreaks of Cronobacter infections in the and were primarily linked to contaminated powdered (PIF) in the and , resulting in 4-6 reported infant deaths. In 1988, the first documented U.S. outbreak occurred in a , neonatal intensive care unit, where four infants developed infections, including three cases of (one with ) and one urinary tract infection, traced to contaminated formula preparation equipment. In 1998, a Belgian reported a cluster of 12 neonatal cases of associated with PIF, leading to the deaths of twin infants; environmental swabs confirmed Cronobacter in the neonatal unit. A significant outbreak in 2001 at a Tennessee neonatal intensive care unit involved three neonates who developed E. sakazakii infections after consuming powdered infant formula from the same lot, with two fatalities among premature neonates. The U.S. Centers for Disease Control and Prevention (CDC) investigation identified Cronobacter sakazakii in opened formula containers and patient stool samples, highlighting risks from improper reconstitution practices. In 2011, reports of neonatal Cronobacter infections in New Zealand were linked to hospital-use PIF, resulting in a cluster of three cases and prompting immediate product recalls and enhanced hygiene protocols in neonatal units. The 2022 U.S. incident involving Abbott Nutrition's PIF led to widespread recalls after Cronobacter sakazakii was confirmed in the manufacturing facility, amid four confirmed infant infections and two deaths where Cronobacter may have contributed. The U.S. Food and Drug Administration (FDA) investigation revealed environmental contamination at the Sturgis, Michigan, plant, affecting products like Similac, Alimentum, and EleCare, and triggered a national shortage of infant formula. Across these events, common response patterns include immediate product recalls, facility shutdowns for deep cleaning, and implementation of enhanced microbiological testing standards, contributing to an estimated total of over 100 documented Cronobacter cases globally since 1950.

Detection and Control

Identification Methods

Identification of Cronobacter species relies on a combination of culture-based and molecular techniques to detect and confirm the presence of this pathogen in food, environmental, and clinical samples. The international standard ISO 22964:2017 provides a horizontal method for detection, starting with pre-enrichment in buffered peptone water to resuscitate stressed cells, followed by selective enrichment in media like modified lauryl sulfate-tryptose broth supplemented with vancomycin to inhibit competing flora. Samples are then plated on chromogenic agars, such as Druggan-Forsythe-Iversen (DFI) agar, where Cronobacter colonies typically appear blue-green due to α-glucosidase activity hydrolyzing a chromogenic substrate. Presumptive isolates are confirmed through biochemical profiling using systems like API 20E strips, which assess characteristics such as oxidase negativity, motility, and fermentation patterns to distinguish Cronobacter from closely related Enterobacteriaceae. Molecular methods offer higher specificity and speed for Cronobacter identification. Conventional assays target genes such as rpoB ( β-subunit) or gluA (glucosidase), enabling genus-level detection and species differentiation among the seven recognized Cronobacter . platforms, often using primers for the ompA or zpx genes, provide rapid screening with sensitivities reaching 10² CFU/g in after enrichment, allowing detection within hours post-enrichment. These assays are particularly valuable for high-throughput testing in laboratories. For epidemiological investigations, serotyping and genotyping techniques are employed to trace outbreaks. (PFGE) generates DNA restriction profiles for comparing isolates, aiding in linking cases to contaminated sources during investigations. Whole-genome sequencing (WGS) supports multi-locus sequence typing (MLST) by analyzing seven housekeeping genes, providing high-resolution to identify sequence types (STs) associated with , such as ST4 in neonatal infections. These methods have been instrumental in product recalls, such as those involving contaminated powdered . Detection faces challenges due to Cronobacter's low contamination levels in products, often below 1 CFU/g, necessitating enrichment steps of 24-48 hours to amplify viable cells before or molecular analysis. Differentiation from similar , like or species, requires confirmatory tests, as shared phenotypic traits can lead to false positives in initial screenings. Advances in 2025 have introduced -based detection kits for field applications, such as (RPA) coupled with CRISPR/Cas12a, offering visual, lateral-flow readouts for at sensitivities of 10¹ CFU/mL without laboratory equipment.

Prevention Strategies

Manufacturing controls for powdered (PIF) emphasize strict adherence to guidelines from the Commission, which mandates a for Cronobacter spp., requiring absence in 10 g samples (n=30, c=0, m=0). The U.S. (FDA) requires manufacturers to implement and Critical Control Points (HACCP) plans under 21 CFR part 117 to identify and mitigate biological hazards like Cronobacter, including supply-chain controls for ingredients. These plans incorporate heat treatments, such as in wet-mix processes, as critical control points to eliminate pathogens, with records of time and temperature maintained. To prevent formation, dry cleaning methods like vacuuming and brushing are prioritized in high-hygiene areas, while is minimized and followed by thorough drying; water usage in dry production zones must be controlled to avoid leaks and ensure equipment dryness post-clean-in-place (). Environmental monitoring programs with direct Cronobacter testing, rather than proxy indicators like , are recommended to verify control effectiveness. In healthcare settings, particularly neonatal intensive care units (NICUs), protocols prioritize the use of pasteurized or commercially sterile liquid when available to minimize risks for vulnerable premature or immunocompromised infants. When PIF is necessary, preparation involves reconstituting with boiled to at least 70°C for one minute to inactivate Cronobacter, followed by rapid cooling to a safe feeding temperature under sterile conditions. Strict practices, including , surface disinfection, and use of sterilized equipment, are essential to prevent post-preparation recontamination. Consumer guidelines from the (WHO) advise against feeding PIF reconstituted with unboiled water to infants under two months old, preterm infants, or those with weakened immune systems, recommending instead the use of water heated to a minimum of 70°C. Proper storage of prepared formula at 2–4°C for no more than 24 hours is critical, with any unused portion discarded after two hours at to avoid ; dry storage of unused PIF in its original container, kept dry and away from moisture, prevents recontamination. Regulatory frameworks continue to evolve, with the adopting microbiological criteria aligned with Codex standards, requiring the absence of Cronobacter in 10 g of PIF under Commission Regulation (EC) No 2073/2005. Global surveillance efforts, such as the CDC's PulseNet network, utilize whole-genome sequencing to detect and track Cronobacter isolates from clinical and food sources, facilitating rapid outbreak response. Emerging prevention technologies include UV irradiation, which has demonstrated synergistic bactericidal effects when combined with near-infrared heating, achieving significant reductions in Cronobacter on PIF surfaces without altering nutritional quality. Bacteriophage-based biocontrol, using phage cocktails targeting multiple Cronobacter strains, shows promise in reducing biofilms and in production lines, with up to 73% coverage across tested isolates in laboratory settings. These approaches are under evaluation for integration into HACCP systems to enhance safety beyond traditional methods.

References

  1. [1]
    Cronobacter spp | Microbiology Spectrum - ASM Journals
    The genus Cronobacter consists of a group of opportunistic Gram-negative pathogens associated with severe and potentially life-threatening medical diseases.
  2. [2]
    Deciphering Cronobacter sakazakii pathogenicity - ScienceDirect.com
    The genus Cronobacter consists of seven species, namely, C. sakazakii, C. malonaticus, C. turicensis, C. dublinensis, C. muytjensii, C. condimenti and C ...
  3. [3]
    Invasive Cronobacter infection Among Infants 2024 Case Definition
    Feb 26, 2024 · Cronobacter spp. belong to the order Enterobacterales, which are Gram-negative bacteria. ... Cronobacter spp. are opportunistic pathogens linked ...Background · Laboratory Criteria · Criteria To Distinguish A...
  4. [4]
    Cronobacter sakazakii - FDA
    Aug 8, 2023 · Cronobacter sakazakii, formerly Enterobacter sakazakii, is a germ or pathogenic bacteria that can cause illness, primarily among infants younger than two ...
  5. [5]
    Cronobacter Species in the Built Food Production Environment - NIH
    Originally, six species within the new genus Cronobacter (C. sakazakii, C. malonaticus, C. turicensis, C. muytjensii, C. dublinensis and C. universalis) were ...
  6. [6]
    Cronobacter Species in Powdered Infant Formula and Their ...
    Cronobacter species are Gram-negative, facultative anaerobic, oxidase-negative, catalase-positive, and rod-shaped bacteria belonging to the family ...
  7. [7]
    Cronobacter Sakazakii - an overview | ScienceDirect Topics
    sakazakii are malonate and catalase positive, lack H2S gas production, and are negative for oxidase, methyl red test, urease, indole, phosphoamidase, d-sorbitol ...
  8. [8]
    Updates on the Cronobacter Genus - Annual Reviews
    Mar 25, 2018 · This review considers our current knowledge of the genus and how DNA-sequence-based methods have contributed considerably to research into ...
  9. [9]
    Analysis of the role of the Cronobacter sakazakii ProP homologues ...
    May 24, 2014 · However, above 6% NaCl only strains expressing ESA_00673, ESA_02131 and ESA_pESA3p05450 demonstrated an ability to grow. ESA_00673 conferred the ...
  10. [10]
    Genotyping and Source Tracking of Cronobacter sakazakii and C ...
    Jul 21, 2015 · Cronobacter spp. are adapted to a wide range of environments, such as water, soil, plant material (wheat, rice, herbs, and spices), food ...Materials And Methods · Bacterial Strains · ResultsMissing: habitat sewage<|control11|><|separator|>
  11. [11]
    Comparative study on Cronobacter sakazakii and Pseudomonas ...
    Comparative study on Cronobacter sakazakii and Pseudomonas otitidis isolated from septic tank wastewater in microbial fuel cell for bioelectricity generation.
  12. [12]
    Occurrence and prevalence of Cronobacter spp. in plant and animal ...
    Sep 24, 2015 · These survival mechanisms will enable the persistence of the bacteria in the environment and dry food samples. The least plant derived food ...
  13. [13]
    Diverse Genotypes of Cronobacter spp. Associated with Dairy Farm ...
    Mar 13, 2024 · Bacteria are capable of forming biofilms on the surface of materials, increasing the possibility of environmental persistence of this pathogen ...
  14. [14]
    Attachment of and Biofilm Formation by Enterobacter sakazakii on ...
    We did a study to determine the effects of temperature and nutrient availability on attachment and biofilm formation by E. sakazakii on stainless steel and ...Missing: plastics | Show results with:plastics
  15. [15]
    Efficacy of disinfectants against Cronobacter biofilm on plastic surfaces
    Apr 13, 2015 · Results show that disinfectants routinely used in food industry are insufficient in removing of Cronobacter biofilm from plastic surfaces.<|control11|><|separator|>
  16. [16]
    Cronobacter Species Contamination of Powdered Infant ... - Frontiers
    Cronobacter strains can therefore survive for relatively long periods (often >2 years) in the desiccated state in PIF and other powdered foods.
  17. [17]
    Cronobacter sakazakii: stress survival and virulence potential in an ...
    The Genus Cronobacter. Cronobacter spp, previously known as Enterobacter sakazakii1 are Gram-negative, rod-shaped, motile, facultative anaerobic bacteria.
  18. [18]
    RNA Sequencing-Based Transcriptional Overview of Xerotolerance ...
    This research led to the identification of candidate genes that play a role in the persistence of this pathogen in desiccated conditions.
  19. [19]
    Cronobacter (Enterobacter sakazakii): An Opportunistic Foodborne ...
    Cronobacter spp. are regarded as ubiquitous organisms having been isolated from a wide variety of foods. These bacteria are opportunistic pathogens.
  20. [20]
    Prevalence and Relative Risk of Cronobacter spp., Salmonella spp ...
    The environmental tolerance of Cronobacter spp. also makes them capable of withstanding food processing (3, 9, 68, 78), allowing flies to potentially ...
  21. [21]
    Dissemination of Cronobacter spp. (Enterobacter sakazakii) in ... - NIH
    The types of airborne contamination found previously in a milk powder production facility include dust, water droplets, and airborne microorganisms (14, 15, 19) ...Missing: insects | Show results with:insects
  22. [22]
    About Cronobacter Infection - CDC
    Sep 29, 2025 · Cronobacter are bacteria that can contaminate dry foods like powdered infant formula, herbal teas, and starches, as well as feeding items ...Missing: soil sewage spices
  23. [23]
    A New Species of “Enterobacteriaceae” Isolated from Clinical ...
    Jan 7, 1980 · Enterobacter sakazakii: A New Species of “Enterobacteriaceae” Isolated from Clinical Specimens. Int J Syst Evol Microbiol 30, 569 (1980) ...
  24. [24]
    The taxonomy of Enterobacter sakazakii: proposal of a new genus ...
    Apr 17, 2007 · Enterobacter sakazakii is an opportunistic pathogen that can cause infections such as necrotizing enterocolitis, bacteraemia, meningitis and brain abscess/ ...
  25. [25]
    Cronobacter gen. nov., a new genus to accommodate the biogroups ...
    Jan 6, 2008 · A new genus to accommodate the biogroups of Enterobacter sakazakii, and proposal of Cronobacter sakazakii gen. nov., comb. nov., Cronobacter malonaticus sp. ...
  26. [26]
    Diversity of the Cronobacter Genus as Revealed by Multilocus ...
    Cronobacter (previously known as Enterobacter sakazakii) is a diverse bacterial genus consisting of seven species: C. sakazakii, C. malonaticus, ...
  27. [27]
    Cronobacter, the emergent bacterial pathogen Enterobacter ...
    Dec 16, 2014 · This paper presents the application of Next Generation Sequencing (NGS) to Cronobacter which has led to the establishment of the Cronobacter PubMLST genome and ...Missing: refinements | Show results with:refinements
  28. [28]
  29. [29]
    [PDF] Cronobacter - Bacteriological Analytical Manual Chapter 29 - FDA
    Cronobacter is a Gram-negative rod within the family Enterobacteriaceae (9). The organism was called. "yellow-pigmented Enterobacter cloacae" until it was ...
  30. [30]
    Genomic Analysis of Cronobacter condimenti s37 - PubMed Central
    Aug 7, 2024 · The genus Cronobacter spp. belongs to the family Enterobacteriaceae and currently includes seven species, such as C. sakazakii, C. malonaticus, ...
  31. [31]
    Genus: Cronobacter - LPSN
    nov., comb. nov., Cronobacter malonaticus sp. nov., Cronobacter turicensis sp. nov., Cronobacter muytjensii sp. nov., Cronobacter dublinensis sp. nov.
  32. [32]
    Draft genomes of Cronobacter sakazakii strains isolated from dried ...
    Nov 29, 2018 · C. sakazakii cells are rod-shaped measuring approximately 3 by 1 μm when the cells are in the exponential growth phase; the cells are motile by ...
  33. [33]
    Insights into the Emergent Bacterial Pathogen Cronobacter spp ...
    Clonal complex 1 currently comprises C. sakazakii STs 1 and 14. ST1 is a ... Major clonal complexes in the Cronobacter MLST database. Clonal complex ...
  34. [34]
    Genomic Analysis of Cronobacter condimenti s37 - MDPI
    Aug 7, 2024 · The genus Cronobacter has undergone a significant transformation during evolution, with species such as C. sakazakii and C. malonaticus ...
  35. [35]
    Insights into virulence factors determining the pathogenicity of ...
    Several studies put forwarded that outer membrane protein A (ompA), contributes significantly to the virulence potential of Cronobacter spp by invading various ...
  36. [36]
    Genomic Analysis of Putative Virulence Factors Affecting Cytotoxicity ...
    Feb 7, 2020 · Moreover, analysis of type VI secretion system (T6SS) cluster and putative fimbria gene clusters of Cronobacter revealed that T6SS have species ...
  37. [37]
    Survival and Environmental Stress Resistance of Cronobacter ...
    Feb 20, 2019 · C. sakazakii has a strong capacity to adapt to elevated osmotic pressure, low pH, heat, oxidation, desiccation, and bile salt (Alvarezordóñez et ...
  38. [38]
    Uncovering virulence factors in Cronobacter sakazakii - NIH
    Sep 26, 2023 · In this study, we aimed to identify specific genes and proteins associated with the virulence of Cronobacter sakazakii, a pathogenic bacterium ...
  39. [39]
    Identification and Characterization of Cronobacter Iron Acquisition ...
    For acquisition of ferric iron (Fe3+), all nine Cronobacter genomes contain genes homologous to the hydroxamate-type siderophore aerobactin (named cronobactin ...Missing: chu | Show results with:chu
  40. [40]
    Invasive Enterobacter sakazakii Disease in Infants - CDC
    Enterobacter sakazakii kills 40%–80% of infected infants and has been associated with powdered formula. We analyzed 46 cases of invasive infant E. sakazakii ...Missing: Cronobacter NEC
  41. [41]
    Cronobacter (Enterobacter sakazakii): an opportunistic foodborne ...
    Clinical symptoms of Cronobacter infection include necrotizing enterocolitis, bacteremia, and meningitis, with case fatality rates of 50-80% being reported.
  42. [42]
    Neonatal Bacterial Meningitis - Pediatrics - Merck Manuals
    Neurologic sequelae (eg, hydrocephalus, hearing loss, intellectual disability) develop in 20 to 50% of infants who survive, with a poorer prognosis when gram- ...
  43. [43]
    Neonatal Meningitis - StatPearls - NCBI Bookshelf - NIH
    For example, the most common signs in neonates weighing over 2500 grams include fever, irritability, seizures, and bulging fontanelle. In contrast, apnea, ...Etiology · Evaluation · Treatment / Management · Prognosis
  44. [44]
    Urinary Tract Infection Caused by Cronobacter sakazakii - PMC
    Jun 20, 2021 · C. sakazakii urinary infection usually occurs as an opportunistic infection in immunocompromised adults or older adults.Missing: wound | Show results with:wound
  45. [45]
    Prevalence and Genetic Diversity of Cronobacter Species Isolated ...
    Aug 21, 2019 · A total of 42 Cronobacter isolates (5%) were detected in 835 environmental samples collected during the surveillance study. These isolates ...
  46. [46]
    Prevalence and Relative Risk of Cronobacter spp., Salmonella spp ...
    Species of Cronobacter have been isolated from a variety of foods, beverages (28, 48), and many other environmental sources, such as soil (50), air (63), ...Missing: global | Show results with:global
  47. [47]
    [PDF] Cronobacter Carriage in Neonate and Adult Intestinal Tracts
    Dec 11, 2012 · translocation to systemic tissue may play an important role in the pathogenesis of Cronobacter. Cronobacter strains colonizing neonatal ...
  48. [48]
    Global and regional prevalence of Cronobacter sakazakii in ...
    Mar 22, 2024 · The continent of Asia (38/88; 43.0%) had the highest studies of Cz, followed by Europe (30/88; 34.0%), Africa and South America (8/88; 9.1%), ...Missing: geographic | Show results with:geographic
  49. [49]
    [PDF] Enterobacter sakazakii (Cronobacter spp.) in powdered follow-up ...
    Enterobacter sakazakii was originally defined as a novel species in 1980 (Farmer et al., 1980). ... These reactions include the utilization of dulcitol ...
  50. [50]
    Occurrence and growth characteristics of Cronobacter species in ...
    The genus currently comprises seven species: C. sakazakii, C. malonaticus, C. universalis, C. turicensis, C. dublinensis, C. muytjensii and C. condimenti ( ...
  51. [51]
    Microbiological survey and genomic analysis of Cronobacter ...
    ABSTRACT. Cronobacter species are opportunistic pathogens that are capable of causing morbidity and mortality, particularly in infants.
  52. [52]
  53. [53]
    The Long, Sad History of Cronobacter and Baby Formula
    Feb 23, 2022 · 1988: At a neonatal intensive care unit in Memphis, Tennessee, the first Cronobacter outbreak in the U.S. occurs. (1) Four infants are sickened ...
  54. [54]
    My 40-Year History with Cronobacter/Enterobacter sakazakii
    Fact: Cronobacter is a typical member of the family Enterobacteriaceae in many ways. This is documented in original 1980 paper by Farmer et al. and further ...
  55. [55]
    Cronobacter spp. in Powdered Infant Formula - ScienceDirect.com
    Mar 1, 2012 · Although Cronobacter can cause disease in both adults and infants, infant infections associated with powdered formula are the focus of this review.
  56. [56]
    Enterobacter sakazakii Infections Associated with the Use of ... - CDC
    Apr 12, 2002 · Enterobacter sakazakii infections associated with the use of powdered infant formula --- Tennessee, 2001.
  57. [57]
    Prevention of Invasive Cronobacter Infections in Young Infants Fed ...
    Nov 1, 2012 · Invasive Cronobacter infection was first reported in 1961 and is now recognized as a rare, often devastating, infection predominantly affecting ...
  58. [58]
    Investigation of Cronobacter Infections from Powdered Infant Formula
    Feb 24, 2022 · The FDA is advising consumers not to use recalled Similac, Alimentum, or EleCare powdered infant formulas.Missing: PIF | Show results with:PIF
  59. [59]
    Emerging of Multidrug-Resistant Cronobacter sakazakii Isolated ...
    Sep 29, 2022 · In 2018, nine provinces had a prevalence of Cronobacter contamination higher than 10.0% (ranging from 23.0% to 13.3%) in supplementary foods, ...
  60. [60]
    Risk analysis of microorganisms in common food spices - Frontiers
    The identified pathogenic risk groups for spice contamination encompass Cocci, Listeria monocytogenes, Shigella, pathogenic Escherichia coli, Cronobacter, ...
  61. [61]
    Cronobacter Sakazakii - an overview | ScienceDirect Topics
    Cronobacter sakazakii is defined as an infrequently isolated opportunistic pathogen associated with life-threatening infections, particularly linked to the ...
  62. [62]
  63. [63]
  64. [64]
    Development and evaluation of rpoB based PCR systems to ...
    ... PCR targeting 16S rRNA, gluA , rpoB and cgcA genes. The 64 Cronobacter isolates were completely identified by the biochemical and rpoB , while the PCR ...
  65. [65]
    Duplex Real-Time PCR Method for the Differentiation of ...
    The detection limit for pure culture was 102 CFU/ml and 103 CFU/g for artificially contaminated rehydrated powdered infant formula. Therefore, the developed ...
  66. [66]
    Cronobacter sakazakii, a Potential Cause of Food-Borne Illness
    Oct 25, 2018 · PFGE and MLST analysis of the six Cronobacter isolates in this outbreak. In silico MLST analysis was performed straightly on the WGS assemblies.
  67. [67]
    DNA sequence-based re-assessment of archived Cronobacter ...
    Jun 28, 2018 · This study re-analyzed, using multi-locus sequence typing (MLST) and whole genome sequence with single nucleotide polymorphism analysis (WGS-SNP), 52 strains
  68. [68]
  69. [69]
    A Simple, Rapid, and Contamination-Free Ultra-Sensitive ... - PubMed
    Sep 6, 2025 · A Simple, Rapid, and Contamination-Free Ultra-Sensitive Cronobacter sakazakii Visual Diagnostic Platform Based on RPA Combined with CRISPR/ ...Missing: 2024 | Show results with:2024
  70. [70]
    [PDF] 2008 Page 1 of 29 This Code replaces CAC/RCP 21-1979
    Powdered formulae – for the purpose of this Code of Practice includes all types of powdered formulae for infants and young children, including: powdered infant ...
  71. [71]
    [PDF] FDA Letter Calling for Enhanced Safety Measures to the Powdered ...
    Mar 8, 2023 · In response, the FDA developed a strategy to prevent future Cronobacter spp. illnesses associated with powdered infant formula and is issuing ...<|control11|><|separator|>
  72. [72]
    Safe preparation, storage and handling of powdered infant formula
    Jun 15, 2012 · The document provides specific guidance on the most appropriate practices in the different steps during the preparation of PIF in these two types of settings.
  73. [73]
    [PDF] B COMMISSION REGULATION (EC) No 2073/2005 of 15 ... - EUR-Lex
    Feb 28, 2019 · This regulation lays down microbiological criteria for certain micro-organisms and the implementing rules for food business operators.
  74. [74]
    PulseNet Timeline - CDC
    May 9, 2024 · 2018 – PulseNet will be able to analyze Yersinia and Cronobacter whole genome sequencing data. 2018 – All 50 state public health laboratories ...
  75. [75]
    Investigating the biocontrol and anti-biofilm potential of a three ...
    Jul 17, 2017 · When all three phages were combined and used as part of a phage cocktail, 73% coverage was obtained across all Cronobacter strains tested.
  76. [76]
    Application of a phage cocktail for the control of Cronobacter and ...
    Phage cocktails can be used to inactivate Cronobacter spp. and eliminate biofilms while reducing the risk of monophage-induced bacterial resistance.